+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Advances in Penile and Testicular Cancer, An Issue of Urologic Clinics of North America. The Clinics: Surgery Volume 51-3

  • Book

  • August 2024
  • Region: North America
  • Elsevier Health Science
  • ID: 5947743
In this issue of Urologic Clinics of North America, guest editors Drs. Jeffrey M. Holzbeierlein and Philippe E. Spiess bring their considerable expertise to the topic of Advances in Penile and Testicular Cancer. Top experts in the field provide important clinical updates on the management of penile and scrotal cancer, discuss the current standards of care using evidence-based treatment guidelines, and provide insight on emerging discoveries. This issue provides critical information and updates needed to improve outcomes in patients with diseases that urologists do not see on a daily basis.
  • Contains 12 relevant, practice-oriented topics, including the psychosocial impact of penile cancer: an unmet need; what is on the horizon in clinical trials for penile and testicular cancer; the use of miRNA to predict teratoma and viable GCT after chemotherapy; testicular cancers survivorship and fertility preservation; and more.
  • Provides in-depth clinical reviews on advances in penile and testicular cancer, offering actionable insights for clinical practice.
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Authors

Jeffrey M. Holzbeierlein Vice President and Physician in Chief, The University of Kansas Cancer Center, Kansas City, KS. Philippe E. Spiess Assistant Chief of Surgical Services, Senior Member, Department of GU Oncology, Medical Director, Virtual Care, Moffitt Cancer Center, Tampa, FL, USA.